Akari Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 19, 2017 11:00 am UTC| Business
NEW YORK and LONDON, Sept. 19, 2017 -- Akari Therapeutics (NASDAQ:AKTX), an emerging growth, clinical-stage biopharmaceutical company, is pleased to announce its Chief Executive Officer Dr. David Horn Solomon and Chief...
Snipp Signs US$250,000 Loyalty Contract with Leading CPG Brand
Sep 19, 2017 11:00 am UTC| Business
WASHINGTON, Sept. 19, 2017 -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB:SNIPF) (TSX VENTURE:SPNV), a global provider of digital marketing promotions, rebates and loyalty solutions, today announced that it...
Oak Realty Group, Inc. Acquires 900,000 Square Foot Industrial Portfolio in Milwaukee Market
Sep 19, 2017 11:00 am UTC| Business
DEERFIELD, Ill., Sept. 19, 2017 -- An affiliate of Deerfield, IL based Oak Realty Group, Inc. (“ORG”) entered the Milwaukee industrial market by acquiring a 879,704 square foot, 10-building industrial portfolio. The...
Ribbon-Cutting Ceremony Held at Husson University for New Townhouses
Sep 19, 2017 11:00 am UTC| Business
Bangor, Maine, Sept. 19, 2017 -- Husson University celebrated the official opening of their new student townhouse apartments on Friday, September 8, 2017 at 2 p.m. Members of the public joined university trustees,...
miRagen Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 19, 2017 11:00 am UTC| Business
BOULDER, Colo., Sept. 19, 2017 -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that William S....
XOMA to Present at the Cantor Fitzgerald Global Healthcare Conference
Sep 19, 2017 11:00 am UTC| Business
BERKELEY, Calif., Sept. 19, 2017 -- XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, today announced that Jim Neal, Chief Executive Officer, will present...
Leap Therapeutics to Present at the 2017 Ladenburg Thalmann Healthcare Conference
Sep 19, 2017 11:00 am UTC| Business
CAMBRIDGE, Mass., Sept. 19, 2017 -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman,...